Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 study.
Journal: The Lancet. Haematology
Published: July 03, 2025
Analyzing the CBC for common pediatric hematologic disorders in primary care.
Journal: Current problems in pediatric and adolescent health care
Published: July 02, 2025
Advances and updates in pediatric anaplastic large cell lymphoma.
Journal: Blood advances
Published: April 30, 2025
Anaplastic large cell lymphoma in children and adolescents.
Journal: British journal of haematology
Published: February 02, 2025
Podcast on Emerging Treatment Options for Pediatric Patients with ALK-Positive Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumors.
Journal: Oncology and therapy
Published: October 05, 2023
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.
Journal: Pediatric blood & cancer
Published: June 30, 2023
Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.
Journal: Frontiers in immunology
Published: April 10, 2023
Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma.
Journal: Best practice & research. Clinical haematology
Published: January 25, 2023
Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 19, 2022
ALK inhibitors for ALK-altered paediatric malignancies.
Journal: The Lancet. Oncology
Published: October 17, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 08, 2021
Last Updated: 09/26/2026